Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Shareholders' Equity

v3.25.1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Series B Conversion
Preferred Class B
Common Stock
Common Stock
Series B Conversion
Preferred Stock
Preferred Class B
Preferred Stock
Preferred Class B
Series B Conversion
Preferred Stock
Preferred Class C
Additional Paid-in Capital
Additional Paid-in Capital
Series B Conversion
Accumulated Other Comprehensive Loss
Retained Earnings
Noncontrolling Interest
Noncontrolling Interest
Series B Conversion
Common stock, beginning balance (in shares) at Dec. 31, 2023       25,671,000                    
Beginning balance at Dec. 31, 2023 $ 764,261     $ 257   $ 0   $ 0 $ 283,684   $ 0 $ 480,320 $ 0  
Preferred stock, beginning balance (in shares) at Dec. 31, 2023           0   0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (88,794)                     (61,712) (27,082)  
Foreign currency translation adjustments (151)                   (151)      
Issuance of share-based awards (in shares)       100,000                    
Issuance of share-based awards 0     $ 1         (1)          
Shares issued - acquisition (in shares)       700,000   4,000   1,000            
Shares issued - acquisition 656,881     $ 7         223,425       433,449  
Share-based compensation expense 1,567               1,567          
Payment of minimum tax withholdings on share-based awards (in shares)       (33,000)                    
Payment of minimum tax withholdings on share-based awards (1,326)                     (1,326)    
Common stock, ending balance (in shares) at Mar. 31, 2024       26,438,000                    
Preferred stock, ending balance (in shares) at Mar. 31, 2024           4,000   1,000            
Ending balance at Mar. 31, 2024 $ 1,332,438     $ 265   $ 0   $ 0 508,675   (151) 417,282 406,367  
Common stock, beginning balance (in shares) at Dec. 31, 2024 29,761,197     29,761,000                    
Beginning balance at Dec. 31, 2024 $ 285,868     $ 298   $ 0   $ 0 542,390   (2,732) (338,228) 84,140  
Preferred stock, beginning balance (in shares) at Dec. 31, 2024 0   10,088     10,000   0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss $ (61,191)                     (50,637) (10,554)  
Foreign currency translation adjustments 265                   265      
Issuance of share-based awards (in shares)       97,000                    
Issuance of share-based awards 0                          
Share-based compensation expense 2,958               2,958          
Payment of minimum tax withholdings on share-based awards (in shares)       (30,000)                    
Payment of minimum tax withholdings on share-based awards $ (894)                     (894)    
Series B - Conversions (in shares)         585,000   (1,000)              
Series B - Conversions   $ 0     $ 6         $ 1,208       $ (1,214)
Common stock, ending balance (in shares) at Mar. 31, 2025 30,413,067     30,413,000                    
Preferred stock, ending balance (in shares) at Mar. 31, 2025 0   9,511     9,000   0            
Ending balance at Mar. 31, 2025 $ 227,006     $ 304   $ 0   $ 0 $ 546,556   $ (2,467) $ (389,759) $ 72,372